Xenopus-derived glucagon-like peptide-1 and polyethylene-glycosylated glucagon-like peptide-1 receptor agonists: long-acting hypoglycaemic and insulinotropic activities with potential therapeutic utilities.
about
Xenopus-derived glucagon-like peptide-1 and polyethylene-glycosylated glucagon-like peptide-1 receptor agonists: long-acting hypoglycaemic and insulinotropic activities with potential therapeutic utilities.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Xenopus-derived glucagon-like ...... tential therapeutic utilities.
@en
Xenopus-derived glucagon-like ...... tential therapeutic utilities.
@nl
type
label
Xenopus-derived glucagon-like ...... tential therapeutic utilities.
@en
Xenopus-derived glucagon-like ...... tential therapeutic utilities.
@nl
prefLabel
Xenopus-derived glucagon-like ...... tential therapeutic utilities.
@en
Xenopus-derived glucagon-like ...... tential therapeutic utilities.
@nl
P2093
P2860
P356
P1476
Xenopus-derived glucagon-like ...... tential therapeutic utilities.
@en
P2093
P2860
P304
P356
10.1111/BPH.14107
P407
P577
2017-11-24T00:00:00Z